Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Nuvalent, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 47 | 49 | +2 |
| Shares | 42.4M | 43.0M | +634.7K (+1.5%) |
| Value | $941.2M | $813.1M | −$128.2M (−13.6%) |
New holders (6)
Institutions that held Nuvalent, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parametric Portfolio Associates LLC | 14,886 | $283.0K | 0.00% |
| Goldman Sachs Group Inc | 14,700 | $280.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 14,000 | $267.0K | 0.00% |
| New York State Common Retirement Fund | 7,802 | $149.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 4,672 | $88.0K | 0.00% |
| Daiwa Securities Group Inc. | 125 | $2.00K | 0.00% |
Sold out (4)
Institutions that held Nuvalent, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Caas Capital Management LP | 120,000 | $2.71M |
| D. E. Shaw & Co., Inc. | 12,142 | $274.0K |
| Ghisallo Capital Management LLC | 10,000 | $226.0K |
| SG Americas Securities, LLC | 4,807 | $108.0K |